Work overview

Section 08 of 08

Declaration of Competing Interest

Adjunctive palivizumab with ribavirin for respiratory syncytial virus infection during the early peri-transplant period in adult allogenic hematopoietic stem cell transplant recipients: Case series

Latefah Aleshaiwi, Afrah Alotaibi, Mohsen Alzahrani, Mohammad Bosaeed, Hajar AlQahtani, and Abdulellah Almohaya · 2026

Contents

Section 08 of 08

  1. 01Introduction
  2. 02Methods
  3. 03Cases (Summarized in Table 1)
  4. 04Discussion
  5. 05Conclusion
  6. 06CRediT authorship contribution statement
  7. 07Ethics declaration
  8. 08Declaration of Competing Interest
Text size
Work overview

Section 8 of 8

Declaration of Competing Interest

Latefah Aleshaiwi, Afrah Alotaibi, Mohsen Alzahrani, Mohammad Bosaeed, Hajar AlQahtani, and Abdulellah Almohaya · about 1 minutes

Original source ↗

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.